P53 gene mutations in human tumors Greenblatt et al. (1995) Cancer Res. 54:4855 50%

Slides:



Advertisements
Similar presentations
Early Embryonic Development Maternal effect gene products set the stage by controlling the expression of the first embryonic genes. 1. Transcription factors.
Advertisements

P53 The Master Guardian of the Genome. p53 gene mutations in human tumors Greenblatt et al. (1995) Cancer Res. 54: %
Retinoblastoma by Michele Chasteen What is Retinoblastoma? n n Tumor of the eye that can occur at a high frequency in children and sporadically at an.
What is Li-Fraumeni syndrome?
A signal transducer and cancer Neurofibromin, ras, and cancer - utah.
CANCER IS A GENETIC DISEASE SUPPORTING EVIDENCE: 1. Hereditary cancer 2. Cancer-causing virus 3. Alterations of cellular genes in cancer 4. Clonal development.
MSH2 and Human Nonpolyposis Colon Cancer Yael Aschner.
P53 gene mutations in human tumors Greenblatt et al. (1995) Cancer Res. 54: %
P53 The Master Guardian. R point Cell cycle control involves several checkpoints and checkpoint (molecular breaking) mechanisms.
Von Hippel-Lindau Syndrome (VHL) Presented by Kelley Montoya March 20, 2003.
BioSci 145A lecture 18 page 1 © copyright Bruce Blumberg All rights reserved BioSci 145A Lecture 18 - Oncogenes and Cancer Topics we will cover today.
Molecular Pathology – Cell cycle Dr. Leonard Da Silva Senior Lecturer Molecular & Cellular Pathology.
MDM2: Oncogene Chan Lee. Discovery of MDM2: starting with tumor suppressor p53.
BRCA2 Blue: Rad51; Green: BRCA2
P73 Shatil Amin March 27 th Content I.Structure and Function II.Regulation III.Is it involved in human cancers?
Protein Mutations in Disease Lecture 11, Medical Biochemistry.
BRCA Genes Dallas Henson.
Please write your field of dissertation on the blank sheet.
Tumor genetics Minna Thullberg
Cancer as a genetic chapter 23 select topics and lecture notes.
Cell Cycle, Cancer, and the Biology Student Workbench An intro to what BSW can do 2002 Steve Moore & Kathy Gabric.
Angelina Jolie The White Coat Wonder. Rational  The purpose of our research is to enrich the Premed-A community with the knowledge of other cancers caused.
Insulin-like signaling pathway: flies and mammals
Last lesson we looked at: What is the definition of a gene?
Familial Cancer. General Principles Mutations inherited through germ cells contribute to a minority of tumours Two hits usually needed germline/somatic.
Cancer &Oncogenes. Objectives Define the terms oncogene, proto-oncogenes and growth factors giving examples. Describe the mechanisms of activations of.
Group Number: 2 Britney Porter, Sandra Nguyen, Eduardo Vargas and Samender Singh Randhawa.
BRCA1: Tumor Suppression and Breast Cancer A breast cancer cell dividing.
P53 Missense Mutation Cancer. Outline Disease related to p53 Role and regulation pathway Structure of p53 Missense mutation and consequences Experiment’s.
CANCER. General A general grouping of all diseases related to unregulated cell growth Cancers generally develop by an accumulation of mutations of the.
CASE #574321F – The Ford Family
Cancer Detection and Diagnosis Early Cancer May Not Have Any symptoms Pap Test Mammograms Blood tests Prostate-specific antigen (PSA) Carcinoembryonic.
Javad Jamshidi Fasa University of Medical Sciences, November 2015 Session 9 Medical Genetics Cancer Genetics.
BRCA2: Breast Cancer Susceptibility Gene 2 Lindy Behrend March 4, 2003.
Javad Jamshidi Fasa University of Medical Sciences, December 2015 Cancer Genetics Session 4 Medical Genetics.
Genes in Action Chapter 14. Sex Linked Traits Another way for traits to be passed on is by being sex linked Female Chromosomes: XX Male Chromosomes: Xy.
Cellular Senescence What is it? What causes it? Why is it important (cancer and aging)?
Cancer Cancer- a malignant tumor; the result of abnormal cell proliferation. Regulation of Cell Division –Tumor Supressor Genes Genes that inhibit cell.
PTEN (Phosphatase and Tensin Homolog) a.k.a. MMAC1, TEP1 Raymond Stadiem.
Cancer. Cancer is a disease of the cell cycle Caused by one or more of the following: Increase in growth signals Loss of inhibitory signals In addition,
Genetic Disorders Cystic Fibrosis
The Basics of Cancer Biology
Cell Cycle Checkpoints The Guardian Mechanisms of
Susceptibility to Inheritance
Mouse Double Minute 2 (MDM2)
p53 function and regulation in normal cells and cancer cells
P53 Tumor Supressor Protein
Patient VB Li-Fraumeni Syndrome.
BRCA1 Breast Cancer.
What makes a mutant?.
Genomic Instability and Cancer
The guardian of the genome
The promise of cancer genetics
B lymphocytes produce antibodies.
PTEN (a.k.a. MMAC1 and TEP1) and Cowden’s Disease
EWS RNA-binding protein What does this protein make up or do?
In search of a cancer gene
Extracellular Regulation of Apoptosis
BIOLOGY 12 Cancer.
Chk1 and Chk2 kinases in checkpoint control and cancer
PTEN Tumor Suppressor Extraordinaire
PTEN Tumor Suppressor and Cancer
Relationship between Genotype and Phenotype
Genetic Heterogeneity in Human Disease
The promise of cancer genetics
Cellular Pliancy and the Multistep Process of Tumorigenesis
Keeping p53 in Check: A High-Stakes Balancing Act
Specific Tumor Suppressor Genes
Tenets of PTEN Tumor Suppression
Presentation transcript:

p53 gene mutations in human tumors Greenblatt et al. (1995) Cancer Res. 54: %

p53 and Ink4a are the two most frequently mutated genes in human tumors

p53 (low) p53 (high) Cell cycle arrest Apoptosis Cellular Stresses (e.g. DNA damage) The Basic Paradigm of p53 Function

The Discovery of p53

SV40 large T protein binds to p53

Li Fraumeni Syndrome An inherited neoplastic disease with autosomal dominant trait Characterised by multiple primary neoplasms in children and young adults A predominance of soft tissue sarcomas (e.g. breast)

Li Fraumeni Syndrome: Childhood and Adult Onset Cancers

Typical Li Fraumeni Syndrome Pedigree In approximately 70% of Li-Fraumeni cases, affected family members carry a germline mutation of one allele of the TP53 tumour suppressor gene.

Inactivation of p53 in Friend murine erythroleukemia

p53 Mutant Mice Develop Cancer

p53 Mutations in Human Tumors are Found with High Frequency In the DNA Binding Domain In 143 families reported: point mutations (85%) deletions (9%) splice mutations (3.5%) insertions (2%)

Ribbon ModelSpace Filling Model p53 Binds DNA The most common mutation changes arginine 248, colored red here. Notice how it snakes into the minor groove of the DNA (shown in blue and green), forming a strong stabilizing interaction. When mutated to another amino acid, this interaction is lost. Other key sites of mutation are shown in pink, including arginine residues 175, 249, 273 and 282, and glycine 245.

p53 Binds DNA as a Tetramer

p53 Functions in Cell Cycle Checkpoints

p53 Mutant Cells Lack Cell Cycle Checkpoint Function

p53 activates p21 (WAF1) El-Deiry et al. (1993) Cell 75:817 GM=Dex inducible WT p53 DEL=Dex inducible mut p53